Title |
Healthcare reform in the United States and China: pharmaceutical market implications
|
---|---|
Published in |
Journal of Pharmaceutical Policy and Practice, July 2014
|
DOI | 10.1186/2052-3211-7-9 |
Pubmed ID | |
Authors |
Arthur Daemmrich, Ansuman Mohanty |
Abstract |
The United States and China are broadening health insurance coverage and increasing spending on pharmaceuticals, in contrast to other major economies that are reducing health spending and implementing a variety of drug price controls. This article analyzes the implications of health system reforms in the United States and China for national pharmaceutical markets. It follows a historical institutionalist approach that identifies path dependency in the design and operation of national health systems. On that basis, we estimate prescription sales for 2015 and 2020, analyze the sustainability of free-market pricing for drugs in the two countries, and assess future competitive dynamics in the pharmaceutical sector. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 40% |
Switzerland | 1 | 20% |
United States | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Science communicators (journalists, bloggers, editors) | 2 | 40% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 65 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 23% |
Student > Ph. D. Student | 9 | 14% |
Student > Master | 8 | 12% |
Student > Bachelor | 8 | 12% |
Student > Doctoral Student | 6 | 9% |
Other | 8 | 12% |
Unknown | 12 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 23% |
Social Sciences | 10 | 15% |
Economics, Econometrics and Finance | 7 | 11% |
Business, Management and Accounting | 5 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
Other | 11 | 17% |
Unknown | 13 | 20% |